Engendering Healthy Masculinities to Prevent Sexual Violence

Status Completed

Clinical Trial Summary

Sexual violence (SV) and adolescent relationship abuse (ARA) are prevalent among adolescents and associated with poor health. Global health organizations highlight engaging men and boys in preventing violence against women as a potentially impactful public health strategy. This study aims to test, via a two arm cluster randomized controlled trial, a "gender transformative" SV/ARA perpetration prevention program among African American adolescent males ages 13-19 (target is high school age) implemented in a community-based setting. "Gender transformative" refers to a theory- and evidence-based approach to alter gender norms that foster SV/ARA while promoting bystander intervention (i.e., giving boys skills to interrupt abusive behaviors they witness among peers) to reduce SV/ARA perpetration. As the acceptance of SV and involvement in unhealthy sexual behaviors are associated with SV/ARA perpetration, this program integrates analysis of social norms that condone violence against women, sexual health promotion, and skills in bystander intervention -- an approach that has been implemented in multiple non-U.S. settings among young adult males with reductions in violence, development of more equitable gender attitudes, and less risky sexual behaviors. This will be the first test of such a gender transformative program among adolescent males in the U.S. Via a 2-arm cluster-randomized trial in youth-serving agencies (16 clusters, N=840 adolescent males ages 14-19), this study will assess the effectiveness of "Manhood 2.0" (proposed name for this gender transformative program) compared to a job skills curriculum. Three months after the end of the program (Time 2), compared to controls, youth will demonstrate increased positive bystander intervention behaviors (secondary outcome). Intermediate outcomes are: condom use self-efficacy; contraception use attitudes; recognition of abusive behaviors; gender-equitable attitudes; and intentions to intervene with peers. Nine months after intervention completion (Time 3), youth will report less perpetration of SV and ARA toward females (Primary Outcome) compared to controls. This study will provide urgently needed information about the effectiveness of a gender transformative program that combines healthy sexuality skills, gender norms change, and bystander skills to interrupt peers' disrespectful and harmful behaviors to reduce SV/ARA perpetration among adolescent males.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02427061
Study type	Interventional
Source	University of Pittsburgh
Contact
Status	Completed
Phase	N/A
Start date	April 2015
Completion date	June 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00729391` - Women-Focused HIV Prevention in the Western Cape	Phase 2/Phase 3
Recruiting	`NCT06062732` - Face It Evaluation	N/A
Withdrawn	`NCT03762356` - Questionnaire About Individual's Insight/Awareness of Risk of Violence
Completed	`NCT02506088` - Preventing Sexual Aggression Among High School Boys	N/A
Completed	`NCT02458365` - A Stage-Based Expert System for Teen Dating Violence Prevention	Phase 2
Completed	`NCT00251212` - Tailored Teen Alcohol and Violence Prevention in the Emergency Room (ER)	N/A
Completed	`NCT00527358` - Evaluation of SAFER Latinos' Program to Prevent Youth Violence	Phase 2/Phase 3
Completed	`NCT01025674` - Randomized Trial of the Positive Action Program in Chicago Schools and Extension to Grade 8	N/A
Completed	`NCT00164541` - An Arts-Based Initiative for the Prevention of Violence Against Women and Girls	Phase 1
Recruiting	`NCT05706376` - An Evidence-based Family Support Program for Parents and Children in Palestine: A Theory-based Intervention	N/A
Recruiting	`NCT06001554` - Preventing Physical and Emotional Violence by Teachers in Public Schools in Pakistan	N/A
Recruiting	`NCT05585918` - The R-CITY Project: A Collaborative Intervention With Teachers and Youth	N/A
Recruiting	`NCT06099262` - GenPMTO Evaluation
Recruiting	`NCT05595759` - Violence Against Women in Patients With Alcohol Substance Addiction Training	N/A
Completed	`NCT05207319` - Effects of Integrated Moral Reasoning Development Intervention for Management of Violence in Schizophrenia	N/A
Completed	`NCT03473067` - Community Level Primary Prevention of Dating and Sexual Violence in Middle Schools	N/A
Completed	`NCT06056661` - Within My Reach (WMR) Adaptation	N/A
Not yet recruiting	`NCT04520399` - Prediction of Violent Behavior in Patients With Schizophrenia by Multimodal Machine Learning
Not yet recruiting	`NCT02257944` - Assessing and Reducing Risk of Violent Re-Injury Among Victims of Urban Violence	N/A
Completed	`NCT01770873` - A Multi-Center Randomized Controlled Trial of Mentoring to Prevent Youth Violence	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.